Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
NCT06772220
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This is a research study investigating elevated homocysteine in the blood of patients with Parkinson's disease who are currently receiving treatment with levodopa. We are evaluating if elevated homocysteine can be corrected using open label B vitamin therapy, as well as the impact of homocysteine levels on cognitive function.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Parkinson&Amp;#39;s Disease
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Not applicable
- Ages
- 40 to 90 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Oregon Health and Science University
- Last updated on ClinicalTrials.gov
- January 13, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Oregon · 1
- Oregon Health & Science University (OHSU) · Portland, OR
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.